1. Introduction {#sec1}
===============

The development of cancer is a multistep process involving aberrations in many cellular processes, including differentiation, cell cycle regulation, cell death, proliferation, and genomic conservation due to functional alterations in a variety of genes.*Thymine DNA glycosylase*(*TDG*) is a member of the mismatch uracil glycosylase subfamily. All of these uracil DNA glycosylase (UDG) enzymes have a monofunctional approach of action \[[@B1]\]. UDGs recruit a common base-flipping, DNA intercalation method for substrate identification and catalyze the removal of the N-glycosidic bond of the flipped base, thus creating an abasic site \[[@B2]\]. TDG has a crucial role in DNA repair, particularly BER, in which it specifically identifies G: U and G: T mismatches resulting from the impulsive deamination of 5-methylcytosine. In addition to its DNA repair function, TDG is also involved in other critical cellular processes, such as the regulation of gene expression, transcriptional coactivation, and the regulation of epigenetic DNA modification \[[@B3]\]. TDG has been shown to interact with some transcription factors and especially with nuclear receptors. TDG initiates the BER pathway, which utilizes the base-flipping method to delete the target bases from the DNA forming an AP site. This happens when TDG binds to the promoters of the BER proteins APE, DNA ligase, and Pol *β* \[[@B4]\].

The role of TDG in cancer progression is a hotly debated issue \[[@B5]\]. Its interaction with tumor suppressor P53 (TP53) proteins initially suggested that TDG merely acts as a tumor suppressor. Overexpression of TDG recruits TP53 proteins to the cyclin dependent kinase inhibitor 1A (p21Waf1) gene promoter and increases its transcriptional activity \[[@B6]\]. Moreover, TP53 binding to the TDG promoter will transcriptionally regulate its expression and control the nuclear translocation of TDG \[[@B7]\]. The relationship between TDG and cancer has been studied by a number of research groups who have suggested that genetic variants in*TDG*and other DNA repair genes confer susceptibility to colorectal cancer \[[@B8]\]. Xu and colleagues showed that*TDG* positively regulates the Wnt signaling pathway and is a key driver necessary for the progression of CRC \[[@B9]\]. They also reported that hypermethylation of*TDG* in multiple myeloma cell lines reduced its gene expression. As a result, DNA repair activity became less efficient \[[@B10]\] in pancreatic adenocarcinoma \[[@B11]\]. Finally, a lack of the DNA mismatch repair protein PMS2 (*PMS2)*and reduced*TDG*expression in rectal cancer has been found to produce a supermutator phenotype at CpG sites \[[@B12]\].

Recent studies reported that the SNP rs2888805 (Val367Met) in*TDG* might be implicated in nonmelanoma skin cancer \[[@B13]\]. The*TDG* SNPs rs167715 and rs4135087 might also be associated with the progression of ovarian cancer in most of the BRCA1/2 mutation carriers \[[@B14]\]. The coding region SNP rs369649741 (Arg66Gly) has been reported to be associated with a high risk in familial colorectal cancer patients \[[@B8]\]. Significant associations have been demonstrated between the risk of cancers, including esophageal squamous cell carcinoma and gastric cancer, and the rs4135054 SNP in*TDG* \[[@B15]\]. This study was conducted to determine the association of the DNA repair gene*TDG* SNPs and colon cancer risk in the Saudi population.

2. Materials and Methods {#sec2}
========================

2.1. Study Population and Patient Selection {#sec2.1}
-------------------------------------------

The study population was composed of 100 colorectal cancer patients and 192 control subjects from a Saudi population. Patients were recruited from King Saud Medical City. CRC was confirmed via histopathological examination. The age of the CRC cases varied from 21 to 90 years, with a mean age of 61.10 ± 12.17 years. The main exclusion conditions were autoimmune disorders, hereditary nonpolyposis colorectal cancer (HNPCC), or a previous history of any other disorders. CRC patients who had undergone prior chemoradiotherapy were also excluded. A total of 192 controls were recruited. The age of the controls varied from 21 to 87 years with a mean of 57.2 ± 8.34 years. The primary details of the volunteers were collected by a prestructured questionnaire. Each participant was informed in detail about the present study and signed standard consent. The Ethics Committee of King Saud Medical City approved the present study.

2.2. Single Nucleotide Polymorphisms (SNPs) Selection, DNA Extraction, and Genotyping {#sec2.2}
-------------------------------------------------------------------------------------

Genomic DNA was extracted from blood samples using a blood DNA kit (QIAGEN DNeasy Blood & Tissue Kit). According to previous reports, six SNPs located in the*TDG* gene were analyzed: rs4135113 (C\_\_31582396_10), rs4135050 (C\_\_\_1970689_10), rs4135066 (C\_\_\_1970695_10), rs3751209 (C\_\_11162283_20), rs1866074 (C\_\_\_3152280_10), and rs1882018 (C\_\_11490839_10). The preliminary data on the SNPs are shown in [Table 1](#tab1){ref-type="table"}. These SNPs were also selected based on literature reviews of SNP associations with various diseases in diverse ethnic groups. The genotyping analysis was conducted using QuantStudio™ 7 Flex Real-Time PCR System (Applied Biosystems) with an endpoint reading of the genotypes \[[@B16]\].

3. Results {#sec3}
==========

A total of 100 colorectal cancer patients and 192 normal controls from a Saudi Arabia population were included in the present study. The clinical and the demographic features of the study subjects are described in Supplementary [Table1](#supplementary-material-1){ref-type="supplementary-material"} (Suppl. [Table1](#supplementary-material-1){ref-type="supplementary-material"}). Both CRC and normal samples were classified based on demographic parameters such as age and gender. Colorectal cancer samples were further classified based on tumor location, namely, colon or rectum. The average age of the CRC samples was 57.10 ± 12.17 years and of the controls was 58.2 ± 8.34 years.

All six SNPs in the normal control and CRC patient group obeyed Hardy-Weinberg equilibrium (HWE) ([Table 1](#tab1){ref-type="table"}). [Table 1](#tab1){ref-type="table"} depicts the details of the SNPs used in the present study including the minor allele frequency and the HWE p-value. Out of the six SNPs, two SNPs, rs4135113 and rs1866074, showed a significant association with colorectal cancer. The genotypic distribution of rs4135113 was 75% GG, 18% GA, and 7% AA in colorectal cancer patients and 82% GG, 16% GA, and 2% AA in normal samples. SNP rs4135113 (Gly199Ser) showed a significant risk association with colorectal cancer in Saudi patients for its genotype AA (OR: 3.640, CI: 1.034--12.819, p = 0.03286) ([Table 2](#tab2){ref-type="table"}). The frequency of the minor allele A in patient samples also showed a significant difference compared with that in the healthy controls (OR: 1.675, CI: 1.013--2.769, p = 0.04264) ([Table 2](#tab2){ref-type="table"}).

The genotypic distribution of rs1866074 was 22% AA, 39% AG, and 39% GG in colorectal cancer patients and 12% AA, 43% AG, and 45% GG in the normal samples. The GG allele frequency was low in colorectal cancer patients compared with that in the controls. SNP rs1866074 showed a protective association of the GG allele (OR: 0.501, CI: 0.251--1, p = 0.047) and the additive (AG+GG) allele (OR: 0.51, CI: 0.269--0.964, p = 0.036) ([Table 2](#tab2){ref-type="table"}). The remaining SNPs, rs4135050, rs4135066, rs3751209, and rs1882018, did not show any association with colorectal cancer in the overall analysis ([Table 2](#tab2){ref-type="table"}).

3.1. Stratification Analysis {#sec3.1}
----------------------------

After an overall analysis, we compared the TDG genotype frequencies based on gender. The genotype distributions of male (n = 58) and female (n = 42) patients were compared with those of matched healthy individuals (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}). Only rs3751209 showed a protective association in female colon cancer patients with the GA genotype (OR, 0.407; CI: 0.196--0.847, p = 0.01495). The heterozygous GA genotype frequency was low in colorectal cancer patients compared with that in the controls ([Table 3](#tab3){ref-type="table"}). No other SNPs showed any significant association with colorectal cancer based on gender (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}). The frequency of the A allele in patient samples also showed a significant difference compared with that of the healthy individuals (OR: 2.238, CI: 1.059--4.729, p = 0.03159).

The*TDG*genotype distribution was further correlated with the age at colon cancer diagnosis and tumor location. To assess the association of the analyzed SNPs with age at colon cancer diagnosis, we divided the patients into two groups based on the median age of the samples: ≤57 (n = 53) or \>57 (n = 47) years of age. The distributions of genotype and allele frequencies for each SNP are shown in Tables [5](#tab5){ref-type="table"} and [6](#tab6){ref-type="table"}. SNP rs4135113, which showed a significant association with CRC in the overall analysis, showed a significant risk association in CRC patients in the group of individuals above 57 years of age. The AA genotype frequency was higher in patients than in healthy individuals. This genotype showed a 5-fold increased risk of colon cancer in the Saudi Arabian population (OR: 5.588; CI: 1.032--30.254; p = 0.02745). In addition to this, the rs4135113 minor allele A also showed a 2-fold increased risk for colorectal cancer in the Saudi population (OR: 2.184, CI: 1.077--4.431; p = 0.02778) ([Table 6](#tab6){ref-type="table"}). A linkage disequilibrium analysis revealed that there was a difference in strength among the SNP associations in cases and controls ([Figure 1](#fig1){ref-type="fig"}).

4. Discussion {#sec4}
=============

To the best of our knowledge, very few studies have been reported which correlate variation in the*TDG*gene with cancer \[[@B16]--[@B18]\]. With the aim of studying the role played by the polymorphisms in the*TDG*gene in CRC risk, we investigated six SNPs (rs4135113, rs4135050, rs4135066, rs3751209, rs1866074, and rs1882018) distributed in different regions of the*TDG*gene. The SNPs were selected based on their location in the*TDG*gene: rs4135113 is located in exon 5; rs4135050, rs4135066, and rs1882018 are in intron 1; and rs3751209 and rs1866074 are in intron 2 and intron 3, respectively. We chose these SNPs to study the effect of mutations in exons and introns. Mutations in an exon might affect the synthesized protein, whereas intron mutations might affect the RNA processing machinery and RNA splicing and stability, which could impact the level of expression and/or protein output \[[@B17]\]. Five of the SNPs were located in intronic region and four of them are in regulatory regions. SNPs rs4135066, rs4135050, and rs1882018 are located in aligned intronic regions flanking alternative conserved exon region (ACE). SNPs rs4135050 and rs1882018 are in exonic splicing silencer (ESS) region, and rs1866074 is in exonic splicing enhancer region.

All six SNPs in the normal control and CRC patient group obeyed the Hardy-Weinberg equilibrium (HWE). Out of the six SNPs, two showed a significant association with CRC. SNP rs4135113 showed a significant risk association of its genotype AA (OR: 3.640, CI: 1.0341--2.819, p = 0.03286) and of the minor allele A (OR: 1.675, CI: 1.013--2.769, p = 0.04264) with colorectal cancer in Saudi patients. The SNP rs1866074 showed a protective association of the GG allele (OR: 0.501, CI: 0.251--1, p = 0.047) and the additive (AG+GG) allele (OR: 0.51, CI: 0.269--0.964, p = 0.036). Our genotyping results showed that there was no association of the other four SNPs (rs4135050, rs4135066, rs3751209, and rs1882018) with CRC patients in the Saudi population in the overall analysis.

The SNP located in the coding region of the*TDG*gene, rs4135113, a G/A transition (missense mutation, Gly199Ser), was studied to detect if there was any association with CRC. There is recent evidence supporting an association between this polymorphism and the development of cancer. Sjolund et al. \[[@B15]\] reported that the Gly199Ser polymorphism occurs in approximately 10% of the global population and the expression of TDG with the G199S variant in human breast epithelial cells might lead to an increased number of DNA double-strand breaks. Thus, it initiates and activates DNA damage that induces cellular transformation and chromosomal aberrations \[[@B18]\]. Our results showed that the A/A genotype variation increases the risk of CRC by approximately fourfold in Saudi patients and is statistically significant (OR= 3.64, p-value = 0.03) ([Table 2](#tab2){ref-type="table"}). Further investigation was conducted to explore the correlation of this polymorphic site with the clinicopathological factors and we observed that rs4135113 showed a fivefold increased risk in old aged patients. A study carried out by Wen-Bin and colleagues (2009) on a Chinese population showed a significant association of rs4135113 with an increased micronucleus in the Chinese population. A few other studies have reported that this SNP has no association with an increased risk of lung cancer, rectal cancer, or gastric adenocarcinoma in a Polish population and a Chinese population \[[@B19]--[@B21]\].

We also investigated the effect of rs4135050 on the risk of CRC when the T was substituted by A. The genotype AA in our study showed an elevated CRC risk, although the difference was not statistically significant ([Table 2](#tab2){ref-type="table"}). In an urban Puerto Rican population, the one-carbon nutrient status was not associated with the DNA uracil concentration in this SNP \[[@B22]\].

The SNP rs4135066 has the C substituted by a T. In this investigation, the homozygous TT showed an increased risk of CRC; however, this was not statistically significant ([Table 2](#tab2){ref-type="table"}). A recent study by Barry et al. in an American population showed that the SNP rs4135066 was not statistically associated with prostate cancer \[[@B23]\]. In the rs3751209 polymorphism, the A/G variation in our study showed a reduction in the CRC risk, but the difference did not reach statistical significance ([Table 2](#tab2){ref-type="table"}). A recent study by Osorio et al. showed that this SNP was not associated with breast cancer risk in BRCA1/2 mutation carriers \[[@B14]\]. Another SNP studied was rs1866074, which is located in the intronic region and results from a transition mutation where A is substituted by G. A recent case control study showed that the increase in the frequency of micronuclei in bladder cancer among the AG and GG carriers improved patient prognosis \[[@B24]\]. In this investigation, we observed that the GG genotype and the AG+GG additive genotype decreased the risk of CRC ([Table 2](#tab2){ref-type="table"}). Finally, rs1882018 was studied during this investigation, which is also located in the intronic region and is produced as a result of a transition mutation where A is substituted by G. Our results showed that the GG genotype increased the risk of BC, but the finding did not reach statistical significance ([Table 2](#tab2){ref-type="table"}). A previous study carried out by Wei et al. showed that this SNP had a protective effect against the development of bladder cancer \[[@B25]\].

5. Conclusions {#sec5}
==============

In conclusion, the present study showed a significant association between the*TDG* gene and colorectal cancer progression in a Saudi population. One of the six*TDG* SNPs showed an increased risk of colon cancer.*TDG* rs4135113 increased the risk of colon cancer development by more than 3.6- and 1.6-fold in CRC patients in general, and 5-fold in patients aged more than 57 years. SNP rs1866074 showed a significant protective association in CRC patients. The GA genotype of*TDG* rs3751209 showed a decreased risk of CRC in males. Thus, there is a significant relationship between*TDG* gene function and colorectal cancer progression. However, further studies are required to determine the exact effect of amino acid (Gly199Ser) replacement using in vitro methods.
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*Suppl. Table 1*: General clinical parameters of the study participants.
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Click here for additional data file.

![Pairwise LD among the six SNPs in colon cancer and controls. The bright red color indicates a high D′.](JO2019-7091815.001){#fig1}

###### 

Primary information for *TDG*polymorphisms.

  --------------------- ------------------ ----------- ----------- ----------- ----------- -----------
  Genotyped SNP         rs4135113          rs4135050   rs4135066   rs3751209   rs1882018   rs1866074
                                                                                           
  Chromosome            12                 12          12          12          12          12
                                                                                           
  Chromosome Position   103982915          103968698   103972562   103979822   103969403   103980664
                                                                                           
  Base change           G\>A (Gly199Ser)   T\>A        C\>T        G\>A        C\>T        A\>G
                                                                                           
  MAF in our controls   0.10               0.21        0.77        0.31        0.23        0.66
                                                                                           
  p*-*value for HWE     0.11               0.11        0.09        0.4         0.09        0.52
  --------------------- ------------------ ----------- ----------- ----------- ----------- -----------

MAF: minor allele frequency.

HWE: Hardy--Weinberg equilibrium.

###### 

Genotype frequencies of *TDG* gene polymorphism in colorectal cases and controls.

  SNP         Variant      Patients Cases   Controls     OR              CI     *χ* ^2^ Value   p-value
  ----------- ------------ ---------------- ------------ --------------- ------ --------------- ---------
  rs4135050   TT           58 (0.58)        124 (0.65)   Ref                                     
  TA          34 (0.34)    55 (0.29)        1.322        0.779--2.244    1.07   0.30107         
  AA          8 (0.08)     12 (0.06)        1.425        0.553--3.676    0.54   0.46173         
  TA+AA       42 (0.42)    67 (0.35)        1.340        0.816--2.201    1.34   0.24664         
  T           150 (0.75)   303 (0.79)       Ref                                                 
  A           50 (0.25     79 (0.21)        1.278        0.853--1.916    1.42   0.23347         
                                                                                                
  rs1882018   CC           58 (0.58)        118 (0.62)   Ref                                     
  CT          32 (0.32)    59 (0.31)        1.103        0.648--1.880    0.13   0.71725         
  TT          10 (0.10)    14 (0.07)        1.453        0.609--3.470    0.71   0.39800         
  CT+TT       42 (0.42)    73 (0.38)        1.171        0.715--1.916    0.39   0.53104         
  C           148 (0.74)   295 (0.77)       Ref                                                 
  T           52 (0.26)    87 (0.23)        1.191        0.802--1.771    0.75   0.38613         
                                                                                                
  rs4135066   CC           4 (0.04)         14 (0.08)    Ref                                     
  CT          38 (0.38)    58 (0.30)        2.293        0.702--7.493    1.96   0.16114         
  TT          58 (0.58)    119 (0.62)       1.706        0.538--5.413    0.84   0.35998         
  CT+TT       96 (0.96)    177 (0.92)       1.898        0.608--5.927    1.25   0.26277         
  C           46 (0.23)    86 (0.23)        Ref                                                 
  T           154 (0.77)   296 (0.77)       0.973        0.647--1.462    0.02   0.89402         
                                                                                                
  rs3751209   GG           51 (0.51)        87 (0.46)    Ref                                     
  GA          38 (0.38)    88 (0.46)        0.737        0.441--1.232    1.36   0.24320         
  AA          11 (0.11)    16 (0.08)        1.173        0.505--2.722    0.14   0.71041         
  GA+AA       49 (0.49)    104 (0.54)       0.804        0.495--1.305    0.78   0.37654         
  G           140 (0.70)   262 (0.69)       Ref                                                 
  A           60 (0.30)    120 (0.31)       0.936        0.645--1.357    0.12   0.72602         
                                                                                                
  rs1866074   AA           22 (0.22)        24 (0.12)    Ref                                     
  AG          39 (0.39)    82 (0.43)        0.519        0.260--1.037    3.50   0.06152         
  GG          39 (0.39)    85 (0.45)        *0.501*      0.251--1.000    3.91   *0.04799*       
  AG+GG       78 (0.78)    167 (0.88)       *0.510*      0.269--0.964    4.39   *0.03615*       
  A           83 (0.42)    130 (0.34)       Ref                                                 
  G           117 (0.58)   252 (0.66)       0.727        0.511--1.034    3.16   0.07567         
                                                                                                
  rs4135113   GG           75 (0.75)        156 (0.82)   Ref                                     
  GA          18 (0.18)    31 (0.16)        1.208        0.635--2.297    0.33   0.56458         
  AA          7 (0.07)     4 (0.02)         3.640        1.034--12.819   4.55   *0.03286*       
  GA+AA       25 (0.25)    35 (0.18)        1.486        0.830--2.660    1.79   0.18130         
  G           168 (0.84)   343 (0.90)       Ref                                                 
  A           32 (0.16)    39 (0.10)        1.675        1.013--2.769    4.11   *0.04264*       

###### 

Genotype frequencies of *TDG* gene polymorphisms in male colorectal cases and controls.

  SNP         Variant     Patients Cases   Controls    OR              CI      *χ* ^2^ Value   p-value
  ----------- ----------- ---------------- ----------- --------------- ------- --------------- ---------
  rs4135050   TT          32 (0.55)        60 (0.63)   Ref                                      
  TA          21 (0.36)   27 (0.28)        1.458       0.714--2.977    1.08    0.29910         
  AA          5 (0.09)    8 (0.08)         1.172       0.354--3.879    0.07    0.79493         
  TA+AA       26 (0.45)   35 (0.37)        1.393       0.717--2.707    0.96    0.32771         
  T           85 (0.73)   147 (0.77)       Ref                                                 
  A           31 (0.27)   43 (0.23)        1.247       0.731--2.126    0.66    0.41728         
                                                                                               
  rs1882018   CC          35 (0.60)        60 (0.63)   Ref                                      
  CT          18 (0.31)   27 (0.29)        1.143       0.552--2.366    0.13    0.71901         
  TT          5 (0.09)    8 (0.08)         1.071       0.325--3.531    0.01    0.90971         
  CT+TT       23 (0.40)   35 (0.37)        1.127       0.576--2.204    0.12    0.72787         
  C           88 (0.76)   147 (0.77)       Ref                                                 
  T           28 (0.24)   43 (0.23)        1.088       0.631--1.875    0.09    0.76200         
                                                                                               
  rs4135066   CC          3 (0.05)         7 (0.07)    Ref                                      
  CT          21 (0.36)   30 (0.32)        1.633       0.378--7.054    0.44    0.50827         
  TT          34 (0.59)   58 (0.61)        1.368       0.332--5.643    0.19    0.66390         
  CT+TT       55 (0.95)   88 (0.93)        1.458       0.362--5.877    0.28    0.59390         
  C           27 (0.23)   44 (0.23)        Ref                                                 
  T           89 (0.77)   146 (0.77)       0.993       0.575--1.716    0.001   0.98108         
                                                                                               
  rs3751209   GG          36(0.62)         44 (0.46)   Ref                                      
  GA          15 (0.26)   45 (0.47)        *0.407*     0.196--0.847    5.92    0.01495         
  AA          7 (0.12)    6 (0.07)         1.426       0.440--4.622    0.35    0.55296         
  GA+AA       22 (0.38)   51 (0.54)        0.527       0.271--1.027    3.58    0.05840         
  G           87 (0.75)   133 (0.70)       Ref                                                 
  A           29 (0.25)   57 (0.30)        0.778       0.461--1.311    0.89    0.34517         
                                                                                               
  rs1866074   AA          12 (0.20)        12 (0.13)   Ref                                      
  AG          23 (0.40)   40 (0.42)        0.575       0.222--1.487    1.32    0.25137         
  GG          23 (0.40)   43 (0.45)        0.535       0.208--1.379    1.70    0.19227         
  AG+GG       46 (0.80)   83 (0.87)        0.554       0.230--1.333    1.77    0.18362         
  A           47 (0.41)   64 (0.34)        Ref                                                 
  G           69 (0.59)   126 (0.66)       0.746       0.463--1.202    1.45    0.22776         
                                                                                               
  rs4135113   GG          45 (0.78)        75 (0.79)   Ref                                      
  GA          9 (0.16)    18 (0.19)        0.833       0.345--2.012    0.16    0.68491         
  AA          4 (0.07)    2 (0.02)         3.333       0.587--18.937   2.05    0.15266         
  GA+AA       13 (0.22)   20 (0.21)        1.083       0.492--2.387    0.04    0.84257         
  G           99 (0.85)   168 (0.88)       Ref                                                 
  A           17 (0.15)   22 (0.12)        1.311       0.664--2.588    0.61    0.43370         

###### 

Genotype frequencies of *TDG* gene polymorphisms in female colorectal cases and controls.

  SNP         Variant     Patients Cases   Controls    OR              CI       *χ* ^2^ Value   p-value
  ----------- ----------- ---------------- ----------- --------------- -------- --------------- ---------
  rs4135050   TT          26 (0.62)        64 (0.67)   Ref                                       
  TA          13 (0.31)   28 (0.29)        1.143       0.513--2.544    0.11     0.74356         
  AA          3 (0.07)    4 (0.04)         1.846       0.386--8.828    0.60     0.43682         
  TA+AA       16 (0.38)   32 (0.33)        1.231       0.579--2.615    0.29     0.58890         
  T           65 (0.77)   156 (0.81)       Ref                                                  
  A           19 (0.23)   36 (0.19)        1.267       0.677--2.370    0.55     0.45905         
                                                                                                
  rs1882018   CC          23 (0.55)        58 (0.60)   Ref                                       
  CT          14 (0.33)   32 (0.34)        1.103       0.500--2.436    0.06     0.80789         
  TT          5 (0.12)    6 (0.06)         2.101       0.584--7.568    1.33     0.24858         
  CT+TT       19 (0.45)   38 (0.40)        1.261       0.606--2.623    0.39     0.53475         
  C           60 (0.71)   148 (0.77)       Ref                                                  
  T           24 (0.29)   44 (0.23)        1.345       0.753--2.405    1.01     0.31578         
                                                                                                
  rs4135066   CC          1 (0.02)         8 (0.08)    Ref                                       
  CT          17 (0.40)   28 (0.29)        4.857       0.558--42.3     2.40     0.12134         
  TT          24 (0.57)   60 (0.63)        3.200       0.379--26.983   1.26     0.26149         
  CT+TT       41 (0.98)   88 (0.92)        3.727       0.451--30.794   1.70     0.19254         
  C           19 (0.23)   44 (0.23)        Ref                                                  
  T           65 (0.77)   148 (0.77)       1.017       0.552--1.876    0.0012   0.95677         
                                                                                                
  rs3751209   GG          15 (0.36)        43 (0.45)   Ref                                       
  GA          23 (0.54)   43 (0.45)        1.533       0.706--3.331    1.17     0.27879         
  AA          4 (0.10)    10 (0.10)        1.147       0.313--4.207    0.04     0.83645         
  GA+AA       27 (0.64)   53 (0.55)        1.460       0.691--3.087    0.99     0.32021         
  G           53 (0.63)   129 (0.67)       Ref                                                  
  A           31 (0.37)   63 (0.33)        1.198       0.701--2.047    0.44     0.50919         
                                                                                                
  rs1866074   AA          10 (0.24)        12 (0.14)   Ref                                       
  AG          16 (0.38)   42 (0.44)        0.457       0.165--1.265    2.32     0.12761         
  GG          16 (0.38)   42 (0.44)        0.457       0.165--1.265    2.32     0.12761         
  AG+GG       32 (0.76)   84 (0.88)        0.457       0.180--1.162    2.79     0.09493         
  A           36 (0.43)   66 (0.34)        Ref                                                  
  G           48 (0.57)   126 (0.66)       0.698       0.413--1.180    1.80     0.17917         
                                                                                                
  rs4135113   GG          30 (0.71)        81 (0.84)   Ref                                       
  GA          9 (0.21)    13 (0.14)        1.869       0.725--4.821    1.71     0.19133         
  AA          3 (0.07)    2 (0.02)         4.050       0.645--25.439   2.56     0.10991         
  GA+AA       12 (0.29)   15 (0.16)        2.160       0.908--5.140    3.11     0.07773         
  G           69 (0.82)   175 (0.91)       Ref                                                  
  A           15 (0.18)   17 (0.09)        2.238       1.059--4.729    4.62     0.03159         

###### 

Genotype frequencies of *TDG* gene polymorphisms in colorectal cases and controls in the below-57-year-old group.

  SNP         Variant     Patients Cases   Controls    OR              CI     *χ* ^2^ Value   p-value
  ----------- ----------- ---------------- ----------- --------------- ------ --------------- ---------
  rs4135050   TT          31 (0.58)        67 (0.68)   Ref                                     
  TA          19 (0.36)   25 (0.25)        1.643       0.789--3.418    1.78   0.18271         
  AA          3 (0.06)    7 (0.07)         0.926       0.224--3.824    0.01   0.91567         
  TA+AA       22 (0.42)   32 (0.32)        1.486       0.745--2.962    1.27   0.25944         
  T           81 (0.76)   159 (0.80)       Ref                                                
  A           25 (0.24)   39 (0.20)        1.258       0.712--2.223    0.63   0.42813         
                                                                                              
  rs1882018   CC          30 (0.57)        61 (0.62)   Ref                                     
  CT          17 (0.32)   31 (0.31)        1.115       0.534--2.327    0.08   0.77161         
  TT          6 (0.11)    7 (0.07)         1.743       0.538--5.642    0.87   0.34986         
  CT+TT       23 (0.43)   38 (0.38)        1.231       0.625--2.423    0.36   0.54797         
  C           77 (0.73)   153 (0.77)       Ref                                                
  T           29 (0.27)   45 (0.23)        1.281       0.745--2.200    0.80   0.36989         
                                                                                              
  rs4135066   CC          2 (0.04)         9 (0.09)    Ref                                     
  CT          21 (0.40)   31 (0031)        3.048       0.598--15.547   1.93   0.16466         
  TT          30 (0.56)   59 (0.60)        2.288       0.465--11.265   1.08   0.29768         
  CT+TT       51 (0.96)   90 (0.91)        2.550       0.530--12.260   1.45   0.22791         
  C           25 (0.24)   49 (0.25)        Ref                                                
  T           81 (0.76)   149 (0.75)       1.066       0.613--1.851    0.05   0.82191         
                                                                                              
  rs3751209   GG          26 (0.49)        46 (0.46)   Ref                                     
  GA          20 (0.38)   44 (0.44)        0.804       0.394--1.643    0.36   0.54978         
  AA          7 (0.13)    9 (0.10)         1.376       0.459--4.128    0.33   0.56807         
  GA+AA       27 (0.51)   53 (0.54)        0.901       0.462--1.758    0.09   0.76037         
  G           72 (0.68)   136 (0.69)       Ref                                                
  A           34 (0.32)   62 (0.31)        1.036       0.624--1.719    0.02   0.89161         
                                                                                              
  rs1866074   AA          13 (0.25)        13 (0.13)   Ref                                     
  AG          22 (0.42)   42 (0.42)        0.524       0.208--1.322    1.90   0.16815         
  GG          18 (0.33)   44 (0.43)        0.409       0.159--1.052    3.53   0.06029         
  AG+GG       40 (0.75)   86 (0.87)        0.465       0.198--1.094    3.16   0.07536         
  A           48 (0.45)   68 (0.34)        Ref                                                
  G           58 (0.55)   130 (0.66)       0.632       0.390--1.023    3.50   0.06132         
                                                                                              
  rs4135113   GG          41 (0.77)        80 (0.81)   Ref                                     
  GA          10 (0.19)   17 (0.17)        1.148       0.482--2.732    0.10   0.75528         
  AA          2 (0.04)    2 (0.02)         1.951       0.265--14.35    0.45   0.50442         
  GA+AA       12 (0.23)   19 (0.19)        1.232       0.546--2.784    0.25   0.61496         
  G           92 (0.87)   177 (0.89)       Ref                                                
  A           14 (0.13)   21 (0.11)        1.283       0.623--2.639    0.46   0.49826         

###### 

Genotype frequencies of *TDG* gene polymorphisms in colorectal cases and controls in the above-57-year-old group.

  SNP         Variant     Patients Cases   Controls    OR              CI     *χ* ^2^ Value   p-value
  ----------- ----------- ---------------- ----------- --------------- ------ --------------- ---------
  rs4135050   TT          27 (0.57)        57 (0.62)   Ref                                     
  TA          15 (0.32)   30 (0.33)        1.056       0.488--2.281    0.02   0.89062         
  AA          5 (0.11)    5 (0.05)         2.111       0.563--7.914    1.27   0.25994         
  TA+AA       20 (0.43)   35 (0.38)        1.206       0.590--2.466    0.26   0.60699         
  T           69 (0.73)   144 (0.78)       Ref                                                
  A           25 (0.27)   40 (0.22)        1.304       0.733--2.321    0.82   0.36543         
                                                                                              
  rs1882018   CC          28 (0.60)        57 (0.62)   Ref                                     
  CT          15 (0.32)   28 (0.30)        1.091       0.503--2.363    0.05   0.82605         
  TT          4 (0.08)    7 (0.08)         1.163       0.314--4.307    0.05   0.82075         
  CT+TT       19 (0.40)   35 (0.38)        1.105       0.539--2.267    0.07   0.78518         
  C           71 (0.76)   142 (0.77)       Ref                                                
  T           23 (0.24)   42 (0.23)        1.095       0.612--1.962    0.09   0.75960         
                                                                                              
  rs4135066   CC          2 (0.04)         5 (0.05)    Ref                                     
  CT          17 (0.36)   27 (0.29)        1.574       0.274--9.045    0.26   0.60894         
  TT          28 (0.60)   60 (0.65)        1.167       0.213--6.387    0.03   0.85883         
  CT+TT       45 (0.94)   87 (0.95)        1.293       0.241--6.930    0.09   0.76356         
  C           21 (0.22)   37 (0.20)        Ref                                                
  T           73 (0.78)   147 (0.80)       0.875       0.478--1.602    0.19   0.66485         
                                                                                              
  rs3751209   GG          25 (0.53)        41 (0.45)   Ref                                     
  GA          18 (0.38)   44(0.47)         0.671       0.320--1.407    1.12   0.28959         
  AA          4 (0.09)    7 (0.08)         0.937       0.249--3.527    0.01   0.92351         
  GA+AA       22 (0.47)   51 (0.55)        0.707       0.349--1.432    0.93   0.33531         
  G           68 (0.72)   126 (0.68)       Ref                                                
  A           26 (0.28)   58 (0.32)        0.831       0.480--1.438    0.44   0.50706         
                                                                                              
  rs1866074   AA          9 (0.19)         11 (0.12)   Ref                                     
  AG          17 (0.36)   4 (0.43)         0.519       0.182--1.481    1.52   0.21694         
  GG          21 (0.45)   41 (0.45)        0.626       0.224--1.747    0.81   0.36892         
  AG+GG       38 (0.81)   81 (0.88)        0.573       0.219--1.500    1.31   0.25305         
  A           35 (0.37)   62 (0.34)        Ref                                                
  G           59 (0.63)   122 (0.66)       0.857       0.510--1.438    0.34   0.55817         
                                                                                              
  rs4135113   GG          34 (0.72)        76 (0.83)   Ref                                     
  GA          8 (0.17)    14 (0.15)        1.277       0.490--3.33     0.25   0.61607         
  AA          5 (0.11)    2 (0.02)         *5.588*     1.032--30.254   4.86   0.02745         
  GA+AA       13 (0.28)   16 (0.17)        1.816       0.787--4.191    1.99   0.15870         
  G           76 (0.81)   166 (0.90)       Ref                                                
  A           18 (0.19)   18 (0.10)        *2.184*     1.077--4.431    4.84   0.02778         

[^1]: Guest Editor: Qingyuan Yang
